Cargando…

Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells

This work aimed at formulating paclitaxel (PTX) loaded cell penetrating peptide (CPP) coated Mn doped ZnS nanoparticles (Mn:ZnS NPs) for improved anti-cancer efficacy in vitro and in vivo. The developed PTX loaded Mn:ZnS NPs with different CPPs (PEN, pVEC and R9) showed enhanced anti-cancer effect c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rejinold, N. Sanoj, Han, Yunho, Yoo, Jisang, Seok, Hae Yong, Park, Ji Ho, Kim, Yeu-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789852/
https://www.ncbi.nlm.nih.gov/pubmed/29382898
http://dx.doi.org/10.1038/s41598-018-20255-x
_version_ 1783296362668883968
author Rejinold, N. Sanoj
Han, Yunho
Yoo, Jisang
Seok, Hae Yong
Park, Ji Ho
Kim, Yeu-Chun
author_facet Rejinold, N. Sanoj
Han, Yunho
Yoo, Jisang
Seok, Hae Yong
Park, Ji Ho
Kim, Yeu-Chun
author_sort Rejinold, N. Sanoj
collection PubMed
description This work aimed at formulating paclitaxel (PTX) loaded cell penetrating peptide (CPP) coated Mn doped ZnS nanoparticles (Mn:ZnS NPs) for improved anti-cancer efficacy in vitro and in vivo. The developed PTX loaded Mn:ZnS NPs with different CPPs (PEN, pVEC and R9) showed enhanced anti-cancer effect compared to bare PTX, which has been validated by MTT assay followed by apoptosis assay and DNA fragmentation analysis. The in vivo bio-distribution and anti-cancer efficacy was studied on breast cancer xenograft model showing maximum tumor localization and enhanced therapeutic efficacy with R9 coated Mn:ZnS NPs (R9:Mn:ZnS NPs) and was confirmed by H/E staining. Thus, R9:Mn:ZnS NPs could be an ideal theranostic nano-carrier for PTX with enhanced  the rapeutic efficacy toward cancer cells, where penetration and sustainability of therapeutics are essential.
format Online
Article
Text
id pubmed-5789852
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57898522018-02-15 Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells Rejinold, N. Sanoj Han, Yunho Yoo, Jisang Seok, Hae Yong Park, Ji Ho Kim, Yeu-Chun Sci Rep Article This work aimed at formulating paclitaxel (PTX) loaded cell penetrating peptide (CPP) coated Mn doped ZnS nanoparticles (Mn:ZnS NPs) for improved anti-cancer efficacy in vitro and in vivo. The developed PTX loaded Mn:ZnS NPs with different CPPs (PEN, pVEC and R9) showed enhanced anti-cancer effect compared to bare PTX, which has been validated by MTT assay followed by apoptosis assay and DNA fragmentation analysis. The in vivo bio-distribution and anti-cancer efficacy was studied on breast cancer xenograft model showing maximum tumor localization and enhanced therapeutic efficacy with R9 coated Mn:ZnS NPs (R9:Mn:ZnS NPs) and was confirmed by H/E staining. Thus, R9:Mn:ZnS NPs could be an ideal theranostic nano-carrier for PTX with enhanced  the rapeutic efficacy toward cancer cells, where penetration and sustainability of therapeutics are essential. Nature Publishing Group UK 2018-01-30 /pmc/articles/PMC5789852/ /pubmed/29382898 http://dx.doi.org/10.1038/s41598-018-20255-x Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rejinold, N. Sanoj
Han, Yunho
Yoo, Jisang
Seok, Hae Yong
Park, Ji Ho
Kim, Yeu-Chun
Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells
title Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells
title_full Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells
title_fullStr Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells
title_full_unstemmed Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells
title_short Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells
title_sort evaluation of cell penetrating peptide coated mn:zns nanoparticles for paclitaxel delivery to cancer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789852/
https://www.ncbi.nlm.nih.gov/pubmed/29382898
http://dx.doi.org/10.1038/s41598-018-20255-x
work_keys_str_mv AT rejinoldnsanoj evaluationofcellpenetratingpeptidecoatedmnznsnanoparticlesforpaclitaxeldeliverytocancercells
AT hanyunho evaluationofcellpenetratingpeptidecoatedmnznsnanoparticlesforpaclitaxeldeliverytocancercells
AT yoojisang evaluationofcellpenetratingpeptidecoatedmnznsnanoparticlesforpaclitaxeldeliverytocancercells
AT seokhaeyong evaluationofcellpenetratingpeptidecoatedmnznsnanoparticlesforpaclitaxeldeliverytocancercells
AT parkjiho evaluationofcellpenetratingpeptidecoatedmnznsnanoparticlesforpaclitaxeldeliverytocancercells
AT kimyeuchun evaluationofcellpenetratingpeptidecoatedmnznsnanoparticlesforpaclitaxeldeliverytocancercells